Related Experiment Video
Updated: Apr 24, 2026
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.2K
Therapeutic and diagnostic challenges for frontotemporal dementia
1Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, College of Medicine, University of Florida Gainesville, FL, USA.
Frontiers in Aging Neuroscience
|September 6, 2014
Summary
Frontotemporal dementia (FTD) research is advancing with new genetic discoveries and insights into TDP-43 and tau proteins. However, FTD remains complex, hindering therapeutic development due to diagnostic and delivery challenges.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Frontotemporal dementia (FTD) is often overlooked compared to Alzheimer's disease (AD).
- Recent discoveries include genetic variants and the identification of TAR DNA binding protein of 43 kDa (TDP-43) in FTD pathology.
- Understanding of tau protein's role in FTD has also expanded.
Purpose of the Study:
- To discuss the challenges in developing therapeutic strategies for FTD.
- To highlight recent advances in FTD research.
- To underscore the complexity of FTD and the need for improved diagnostics and therapies.
Main Methods:
- Review of recent genetic and pathological findings in FTD.
- Analysis of the roles of TDP-43 and tau in neurodegeneration.
- Discussion of challenges in FTD diagnosis and therapeutic delivery.
Main Results:
- FTD is a complex, diverse condition with significant recent research advancements.
- TDP-43 and tau are key proteins implicated in FTD pathogenesis.
- The precise roles of TDP-43 and tau in neurodegeneration remain unclear.
Conclusions:
- Despite advances, FTD remains a complex neurological disorder.
- Accurate diagnosis and advanced technology are crucial for effective FTD therapies.
- Further research is needed to clarify the roles of TDP-43 and tau for therapeutic development.
Related Concept Videos
01:30Dementia
681
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
681
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:22Dementia l: Introduction
29
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
29
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:29Alzheimer Disease l: Introduction
13
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
13
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K